A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
出版年份 2021 全文链接
标题
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
作者
关键词
-
出版物
EBioMedicine
Volume 66, Issue -, Pages 103327
出版商
Elsevier BV
发表日期
2021-04-14
DOI
10.1016/j.ebiom.2021.103327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single-cell analysis based dissection of clonality in myelofibrosis
- (2020) Elena Mylonas et al. Nature Communications
- A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
- (2020) R. Nicolle et al. ANNALS OF ONCOLOGY
- Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
- (2019) Friederike Christen et al. BLOOD
- Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
- (2019) Vitor H. Teixeira et al. NATURE MEDICINE
- Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
- (2019) María Teresa Blasco et al. CANCER CELL
- Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
- (2019) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
- (2018) Jaclyn Andricovich et al. CANCER CELL
- Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
- (2018) Christopher Maximilian Arends et al. LEUKEMIA
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies
- (2016) Simin Manole et al. CANCER RESEARCH
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
- (2016) E Young et al. LEUKEMIA
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
- (2015) Mark Sausen et al. Nature Communications
- Disclosure of Erlotinib as a Multikinase Inhibitor in Pancreatic Ductal Adenocarcinoma
- (2015) Laura Conradt et al. NEOPLASIA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
- (2012) S Boeck et al. BRITISH JOURNAL OF CANCER
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
- (2011) Jean Charles Nault et al. JOURNAL OF HEPATOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy
- (2011) S. T. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now